Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Synthorx, Inc., a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment...
Synthorx Inc. announced today the completion of a $63 million Series C financing, led by OrbiMed and joined by new investors, Medicxi and Osage...
Synthorx Inc. announced today that scientists at The Scripps Research Institute (TSRI) and the company, guided by Floyd Romesberg, Ph.D., have...
Synthorx Inc. announced today that Laura Shawver, Ph.D., was appointed president, chief executive officer (CEO), and director of Synthorx. Dr....
Synthorx Inc., a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment of ...
Synthorx Inc. announced today the completion of a $10 million Series B financing, led by RA Capital Management and joined by Series A investors...
Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.